Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth

[ad_1] Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images SAN FRANCISCO — An established but … Read More

Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch

[ad_1] Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin treating patients, some investors see better times ahead next year. … Read More